Quantitative analysis of respiratory viruses based on lab-on-a-chip platform

Anal Bioanal Chem. 2023 Nov;415(26):6561-6571. doi: 10.1007/s00216-023-04935-w. Epub 2023 Sep 8.

Abstract

The quantitative analysis of respiratory viruses is of great importance for rapid diagnosis, precision medicine, and prognosis. Several current quantitative analysis systems have been proposed and commercialized. Although they have been proven in trials, quantitative analyzes based on real samples are still complex, time-consuming, and expensive. Therefore, they are not able to directly quantify real samples. In this work, we presented a lab-on-a-chip platform combined with an automated control system to achieve quantitative analysis from samples to results. We developed a multilayer integrated chip to rapidly extract and quantify RNA of coronavirus disease 2019 (COVID-19) pseudovirus from large-volume nasal swab samples. The dependence of the magnetic bead size and the interfacial effect was studied for the first time, and the conditions of immiscible filtration assisted by surface tension (IFAST) method for nucleic acid extraction were optimized to increase the nucleic acid recovery rate up to 85%. Inside the chip, a pneumatic valve was developed for automatic opening and closing of the liquid channel. The integrated chip platform and automatic control system presented here are advantageous for use in resource-limited settings (RLS). In addition, our method can be extended to other respiratory viruses and other sample types.

Keywords: Automated; Lab-on-a-chip; Quantitative analysis; Respiratory viruses.

MeSH terms

  • COVID-19* / diagnosis
  • Filtration / methods
  • Humans
  • Lab-On-A-Chip Devices
  • Nucleic Acids* / analysis
  • Viruses*

Substances

  • Nucleic Acids